A drug that lowers blood lipids could treat the world's most common liver disease
The University of Barcelona has led a study that suggests using the drug known as pemafibrate to treat liver disease associated with metabolic disorders, the most common liver pathology in the world, which affects 1 in 4 ...
Jul 10, 2024
0
0